Literature DB >> 34238365

Psychometric properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: systematic review protocol.

Henrique Ceretta Oliveira1, Daisuke Hayashi Neto2, Samantha Dalbosco Lins Carvalho2, Rita de Cássia Lopes Barros2, Mayza Luzia Dos Santos Neves2, Carla Renata Silva Andrechuk2, Neusa Maria Costa Alexandre2, Roberta Cunha Matheus Rodrigues2.   

Abstract

BACKGROUND: The pharmacological treatment of cardiovascular diseases and type 2 diabetes mellitus reduces the risk of cardiovascular events.; however, most patients do not adhere to the treatment. There are several self-reported measures for assessing medication adherence. Identifying the instruments with the best psychometric evidence is essential for selecting an accurate measure. The aim of this study is to critically assess, compare and synthesize the quality of the measurement properties of patient-reported outcome measures to access medication adherence among patients with cardiovascular diseases and/or type 2 diabetes mellitus.
METHODS: This protocol is reported according to Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) and the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. The following databases will be searched: Web of Science, SCOPUS, PubMed, CINAHL, EMBASE, LILACS, PsycINFO and ProQuest. DISCUSSION: This review will provide a detailed assessment of the measurement properties of self-reported medication adherence instruments in patients with cardiovascular diseases and/or type 2 diabetes mellitus to support clinical practice and research. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42019129109.

Entities:  

Keywords:  Cardiovascular diseases; Diabetes mellitus; Medication adherence; Patient reported outcome measures; Psychometrics; Reproducibility of results; type 2

Mesh:

Year:  2021        PMID: 34238365      PMCID: PMC8268561          DOI: 10.1186/s13643-021-01755-w

Source DB:  PubMed          Journal:  Syst Rev        ISSN: 2046-4053


  18 in total

1.  The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2010-07       Impact factor: 6.437

Review 2.  What are validated self-report adherence scales really measuring?: a systematic review.

Authors:  Thi-My-Uyen Nguyen; Adam La Caze; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

3.  COSMIN guideline for systematic reviews of patient-reported outcome measures.

Authors:  C A C Prinsen; L B Mokkink; L M Bouter; J Alonso; D L Patrick; H C W de Vet; C B Terwee
Journal:  Qual Life Res       Date:  2018-02-12       Impact factor: 4.147

Review 4.  Measuring Self-Care in Persons With Type 2 Diabetes: A Systematic Review.

Authors:  Yan Lu; Jiayun Xu; Weigang Zhao; Hae-Ra Han
Journal:  Eval Health Prof       Date:  2015-06-30       Impact factor: 2.651

5.  COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures.

Authors:  L B Mokkink; H C W de Vet; C A C Prinsen; D L Patrick; J Alonso; L M Bouter; C B Terwee
Journal:  Qual Life Res       Date:  2017-12-19       Impact factor: 4.147

6.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2010-02-19       Impact factor: 4.147

7.  Rayyan-a web and mobile app for systematic reviews.

Authors:  Mourad Ouzzani; Hossam Hammady; Zbys Fedorowicz; Ahmed Elmagarmid
Journal:  Syst Rev       Date:  2016-12-05

8.  Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients.

Authors:  Yeon-Yong Kim; Jin-Seok Lee; Hee-Jin Kang; Sang Min Park
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study.

Authors:  C B Terwee; C A C Prinsen; A Chiarotto; M J Westerman; D L Patrick; J Alonso; L M Bouter; H C W de Vet; L B Mokkink
Journal:  Qual Life Res       Date:  2018-03-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.